Clinical Trials Logo

Filter by:
NCT ID: NCT00145925 Completed - Clinical trials for Diabetes Mellitus, Type 2

Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 Diabetes

Start date: June 2001
Phase: Phase 3
Study type: Interventional

The purpose of this study is to provide information on the risks and benefits of routine blood pressure lowering (regardless of blood pressure level), and intensive lowering of blood glucose levels, in patients with Type 2 diabetes at high risk of cardiovascular events. The major outcomes of the study will be cardiovascular events (heart attack, stroke or dying as a result of cardiovascular disease), as well as new or worsening diabetic eye and kidney disease.

NCT ID: NCT00145574 Completed - Clinical trials for Hypercholesterolemia

Efficacy and Safety of Colesevelam in Pediatric Patients With Genetic High Cholesterol

Start date: November 2005
Phase: Phase 4
Study type: Interventional

This study will evaluate the lipid-lowering effect and safety of colesevelam therapy administered to heterozygous familial pediatric patients 10 through 17 years of age who are on a stable dose of a pediatric-approved statin monotherapy (atorvastatin, lovastatin, simvastatin or pravastatin), or who are treatment naive to lipid-lowering therapy.

NCT ID: NCT00145561 Completed - HIV Infections Clinical Trials

The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-infected Pregnant Women.

Start date: August 2005
Phase: Phase 1/Phase 2
Study type: Interventional

Pharmacokinetic study of Saquinavir and Ritonavir in HIV-infected pregnant women

NCT ID: NCT00145444 Completed - Schizophrenia Clinical Trials

Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study

Start date: March 2003
Phase: Phase 3
Study type: Interventional

This study intends to compare novel antipsychotics ziprasidone and olanzapine, to confirm the findings of an open study -where stable patients receiving olanzapine switched to ziprasidone- which showed maintenance of clinical effect with improvements in all domains of cognitive function at 6 weeks (Daniel, 1999). Direct comparison of the two agents in a well-controlled double-blind fashion will allow an evaluation of the effect on cognitive function in the short and long-term management of patients with recent-onset schizophrenia, schizoaffective and schizophreniform disorder.

NCT ID: NCT00145119 Completed - Clinical trials for Acute Myocardial Infarction

CARISMA : Cardiac Arrhythmias and Risk Stratification After MyoCardial Infarction

Start date: August 2001
Phase:
Study type: Observational

The purpose of this study is to assess the incidence of tachy- and bradyarrhythmic episodes in patients with acute myocardial infarction with depressed ventricular function and to determine the predictive value of several invasive and non-invasive risk markers for life-threatening arrhythmia

NCT ID: NCT00145093 Completed - Clinical trials for Diabetes Mellitus, Type 2

Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus

Start date: August 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether chromium (yeast), is effective in improving glycaemic control and insulin resistance.

NCT ID: NCT00145015 Completed - Colorectal Cancer Clinical Trials

FishGastro Study: Fish Consumption and Gastro-Intestinal Health

Start date: December 2004
Phase: N/A
Study type: Interventional

The purpose of the study is to determine whether increasing the dietary intake of n-3 fatty acids by the consumption of oil-rich fish reduces the risk of developing colorectal cancer.

NCT ID: NCT00144859 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD)

Start date: July 2005
Phase: Phase 2
Study type: Interventional

This is a 28-day, placebo controlled clinical study assessing the safety, tolerability anti-inflammatory effect and pharmacokinetics of SB681323 in patients with COPD (Chronic Obstructive Pulmonary Disease).

NCT ID: NCT00144339 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients

Start date: December 2002
Phase: Phase 3
Study type: Interventional

The primary objective of this trial is to determine whether daily treatment with tiotropium (Spiriva®, Bromuro de Tiotropio®) inhalation capsule via HandiHaler® reduces the rate of decline in lung function over time in patients with COPD.

NCT ID: NCT00144261 Completed - HIV Infections Clinical Trials

An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ Subjects

Start date: November 2003
Phase: Phase 4
Study type: Interventional

1. In order to obtain further insight as to how NVP affects HDL metabolism, the in vivo kinetics of the HDL apolipoprotein, Apo A-1, before and 6 weeks after initiation of NVP containing treatment were evaluated. In addition, the activity of the key enzymes related to HDL metabolism were assessed. [ Designated as safety issue: No ] 2. In order to determine the relevance of the HDL increase in decreasing cardiovascular risk in HIV-positive subjects we evaluated endothelial function (FMD) as a surrogate marker for cardiovascular disease in patients. [ Designated as safety issue: No ]